Showing results (41-50 of 58) with videos related to
Sort By:
Pageof 6
Surgery, Gynecology & Obstetrics|November 1, 1990
Time to recurrence varies inversely with thickness in clinical stage 1 cutaneous melanomaS Schultz, M Kane, R Roush, et al.Seminars in Oncology|December 29, 1998
Autologous, hapten-modified vaccine as a treatment for human cancersD Berd, J Kairys, C Dunton, et al.Journal of Leukocyte Biology|May 1, 1990
"Autoregulation" of human neutrophil activation in vitro: regulation of phorbol myristate acetate-induced neutrophil activation by cell densityS P Peters, F Cerasoli, K H Albertine, et al.The Journal of Clinical Investigation|February 15, 1997
Clonal expansion of T lymphocytes in human melanoma metastases after treatment with a hapten-modified autologous tumor vaccineM Sensi, C Farina, C Maccalli, et al.Cancer Research|November 15, 1994
Abnormal expression of perlecan proteoglycan in metastatic melanomasI R Cohen, A D Murdoch, M F Naso, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1996
Interleukin 10 production by human melanomaT Sato, P McCue, K Masuoka, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Autologous hapten-modified melanoma vaccine as postsurgical adjuvant treatment after resection of nodal metastasesD Berd, H C Maguire, L M Schuchter, et al.International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|November 13, 2003
Acute extracellular acidification reduces intracellular pH, 42 degrees C-induction of heat shock proteins and clonal survival of human melanoma cells grown at pH 6.7R A Coss, C W Storck, P R Wachsberger, et al.Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
Phase I study of R24 in patients with metastatic melanoma including evaluation of immunologic parametersH C Maguire, D Berd, E C Lattime, et al.Journal of Experimental & Clinical Cancer Research : CR|June 1, 1997
BOLD+interferon in the treatment of metastatic uveal melanoma: first report of active systemic therapyF E Nathan, D Berd, T Sato, et al.Pageof 6